Jump to main content
Jump to site search

Issue 10, 2015
Previous Article Next Article

An intestinal Trojan horse for gene delivery

Author affiliations

Abstract

The intestinal epithelium forms an essential element of the mucosal barrier and plays a critical role in the pathophysiological response to different enteric disorders and diseases. As a major enteric dysfunction of the intestinal tract, inflammatory bowel disease is a genetic disease which results from the inappropriate and exaggerated mucosal immune response to the normal constituents in the mucosal microbiota environment. An intestine targeted drug delivery system has unique advantages in the treatment of inflammatory bowel disease. As a new concept in drug delivery, the Trojan horse system with the synergy of nanotechnology and host cells can achieve better therapeutic efficacy in specific diseases. Here, we demonstrated the feasibility of encapsulating DNA-functionalized gold nanoparticles into primary isolated intestinal stem cells to form an intestinal Trojan horse for gene regulation therapy of inflammatory bowel disease. This proof-of-concept intestinal Trojan horse will have a wide variety of applications in the diagnosis and therapy of enteric disorders and diseases.

Graphical abstract: An intestinal Trojan horse for gene delivery

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 29 Oct 2014, accepted on 05 Jan 2015 and first published on 06 Jan 2015


Article type: Communication
DOI: 10.1039/C4NR06377E
Citation: Nanoscale, 2015,7, 4354-4360
  •   Request permissions

    An intestinal Trojan horse for gene delivery

    H. Peng, C. Wang, X. Xu, C. Yu and Q. Wang, Nanoscale, 2015, 7, 4354
    DOI: 10.1039/C4NR06377E

Search articles by author